Plasma Adiponectin Concentrations in Patients with Chronic Renal Failure: Relationship with Metabolic Risk Factors and Ischemic Heart Disease

 

 Buy Article Permissions and Reprints

Abstract

Aims: To compare plasma adiponectin levels between healthy controls and patients with chronic renal failure and to examine for a relationship between plasma adiponectin levels and ischemic heart disease as well as aortic distensibility which is an early marker of atherosclerosis. Methods: We included 89 patients with CRF (45 on and 44 not on hemodialysis) and 70 controls in a cross-sectional study. Plasma adiponectin levels were measured by radioimmunoassay. Aortic distensibility was assessed by high-resolution ultrasonography. Results: Plasma adiponectin levels were significantly almost twice as high in patients with renal failure compared to controls (9.7 ± 1.1 vs. 5.4 ± 0.6 µg/ml, p < 0.0001). No significant differences were found between renal patients on hemodialysis and not on hemodialysis (p = 0.71). Multivariate linear regression analysis in the renal patient group demonstrated a significant negative relationship between plasma adiponectin levels and ischemic heart disease (p = 0.02). The same analysis in the control subjects group showed a significant, negative relationship between plasma adiponectin levels and body mass index (p = 0.02) and a highly significant positive relationship with the high density lipoprotein cholesterol (p < 0.0001). In the total study population, glomerular filtration rate was the only independent predictor of plasma adiponectin concentrations. Aortic distensibility was lower in renal patients than in controls at a high level of significance (p < 0.0001). However, no significant relationship could be found between plasma adiponectin and aortic distensibility in either the controls or the renal patients. Conclusions: Plasma adiponectin levels are almost twice as high in patients with chronic renal failure in comparison with healthy controls, but not different between renal patients on and those not on hemodialysis. In addition, low plasma adiponectin levels are strongly associated with ischemic heart disease, but not with aortic distensibility in chronic renal failure.

References

• 1 Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).  Biochem Biophys Res Commun. 1996;  221 286-289
  CrossrefPubMedGoogle Scholar
• 2 Chandran M, Phillips S A, Ciaraldi T, Henry R R. Adiponectin: more than just another fat cell hormone?.  Diabetes Care. 2003;  26 2442-2450
  CrossrefPubMedGoogle Scholar
• 3 Thamer C, Machann J, Tschritter O, Haap M, Wietek B, Dahl D, Bachmann O, Fritsche A, Jacob S, Stumvoll M, Schick F, Haring H U. Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans.  Horm Metab Res. 2002;  34 646-649
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Stefan N, Stumvoll M. Adiponectin-its role in metabolism and beyond.  Horm Metab Res. 2002;  34 469-474
  Article in Thieme ConnectPubMedGoogle Scholar
• 5 Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell.  Circulation. 2002;  18 2893-2898
  PubMedGoogle Scholar
• 6 Diez J J, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease.  Eur J Endocrinol. 2003;  148 293-300
  CrossrefPubMedGoogle Scholar
• 7 Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. Plasma concentrations of a novel adipose specific protein adiponectin in type 2 diabetic patients.  Arterioscler Thromb Vasc Biol. 2000;  20 1595-1599
  CrossrefPubMedGoogle Scholar
• 8 Zoccali C, Mallamaci F, Tripepi G, Benedetto F A, Cutrupi S, Parlongo S, Malatino L S, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.  J Am Soc Nephrol. 2002;  13 134-141
  PubMedGoogle Scholar
• 9 Chudek J, Adamczak M, Karkoszka H, Budzinski G, Ignacy W, Funahashi T, Matsuzawa Y, Cierpka L, Kokot F, Wiecek A. Plasma adiponectin concentration before and after successful kidney transplantation.  Transplant Proc. 2003;  35 2186-2189
  CrossrefPubMedGoogle Scholar
• 10 K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2001 39: S1-246
  Google Scholar
• 11 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003 289: 2560-2571
  Google Scholar
• 12 Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
  Google Scholar
• 13 Stefanadis C, Stratos C, Boudoulas H, Kourouklis C, Toutouzas P. Distensibility of the ascending aorta: comparison of invasive and non-invasive techniques in healthy men and in men with arterial disease.  Eur Heart J. 1990;  11 990-996
  PubMedGoogle Scholar
• 14 Tentolouris N, Liatis S, Moyssakis I, Tsapogas P, Psallas M, Diakoumopoulou E, Voteas V, Katsilambros N. Aortic distensibility is reduced in subjects with type 2 diabetes and cardiac autonomic neuropathy.  Eur J Clin Invest. 2003;  33 1075-1083
  CrossrefPubMedGoogle Scholar
• 15 Hauner H, Hochberg Z. Endocrinology of adipose tissue.  Horm Metab Res. 2002;  34 605-606
  Article in Thieme ConnectPubMedGoogle Scholar
• 16 Mohlig M, Wegewitz U, Osterhoff M, Isken F, Ristow M, Pfeiffer A F, Spranger J. Insulin decreases human adiponectin plasma levels.  Horm Metab Res. 2002;  34 655-658
  Article in Thieme ConnectPubMedGoogle Scholar
• 17 Yamamoto Y, Hirose H, Saito I, Tomita M, Taniyama M, Matsubara K, Okazaki Y, Ishii T, Nishikai K, Saruta T. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population.  Clin Sci (London). 2002;  103 137-142
  PubMedGoogle Scholar
• 18 Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.  Diabetes. 2002;  51 2734-2741
  CrossrefPubMedGoogle Scholar
• 19 Gavrila A, Chan J L, Yiannakouris N, Kontogianni M, Miller L C, Orlova C, Mantzoros C S. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies.  J Clin Endocrinol Metab. 2003;  88 4823-4831
  CrossrefPubMedGoogle Scholar
• 20 Lenchik L, Register T C, Hsu F C, Lohman K, Nicklas B J, Freedman B I, Langefeld C D, Carr J J, Bowden D W. Adiponectin as a novel determinant of bone mineral density and visceral fat.  Bone. 2003;  33 646-651
  CrossrefPubMedGoogle Scholar
• 21 Stamatiadis D N, Chan J L, Cogswell R, Stefanopoulou H C, Bullen J, Katsilambros N, Stathakis C P, Mantzoros C S. Elevated leptin fragments in renal failure correlate with BMI and haematopoiesis and are normalized by haemodialysis.  Clin Endocrinol (Oxf). 2004;  60 434-441
  CrossrefPubMedGoogle Scholar
• 22 Matsabura M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women.  Eur J Endocrinol. 2002;  147 173-180
  CrossrefPubMedGoogle Scholar
• 23 Goldfine A B, Kahn C R. Adiponectin: linking the fat cell to insulin sensitivity.  Lancet. 2003;  362 1431
  CrossrefPubMedGoogle Scholar
• 24 Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miyagawa J, Funahashi T, Matsuzawa Y. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls.  Horm Metab Res. 2000;  32 47-50
  Article in Thieme ConnectPubMedGoogle Scholar
• 25 Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, Nishizawa H, Maeda N, Kobayashi H, Hiraoka H, Matsuzawa Y. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.  Circulation. 2003;  107 671-674
  CrossrefPubMedGoogle Scholar
• 26 Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimburger O, Zhang Z, Hoff C, Holmes C, Axelsson J, Arvidsson S, Schalling M, Barany P, Lindholm B, Nordfors L. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin.  Kidney Int. 2004;  65 274-281
  CrossrefPubMedGoogle Scholar
• 27 Cruickshank K, Riste L, Anderson S G, Wright J S, Dunn G, Gosling R G. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?.  Circulation. 2002;  106 2085-2090
  CrossrefPubMedGoogle Scholar
• 28 Pecoits-Filho R, Heimburger O, Barany P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. Associations between circulating inflammatory markers and residual renal function in CRF patients.  Am J Kidney Dis. 2003;  41 1212-1218
  CrossrefPubMedGoogle Scholar

Prof. N. Katsilambros

1st Department of Propedeutic Medicine, Athens University Medical School ·

5 Doryleou Street · 115 21 Athens · Greece

Phone: +30(210)745-62-61

Fax: +30(210)779-18-39 ·

Email: laennec@techlink.gr